- $3.10bn
- $3.56bn
- $3.52bn
- 90
- 80
- 33
- 75
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,917 | 1,765 | 2,928 | 3,914 | 3,519 |
Cost of Revenue | |||||
Gross Profit | 497 | 491 | 1,126 | 1,640 | 1,340 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,685 | 1,526 | 2,117 | 2,680 | 2,633 |
Operating Profit | 231 | 239 | 811 | 1,234 | 886 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 185 | 202 | 780 | 1,204 | 850 |
Provision for Income Taxes | |||||
Net Income After Taxes | 139 | 152 | 588 | 913 | 690 |
Net Income Before Extraordinary Items | |||||
Net Income | 139 | 152 | 588 | 913 | 690 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 135 | 149 | 576 | 899 | 679 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.79 | 3.16 | 12.2 | 20.4 | 17.7 |